Reference record (b)(4).The device manufacturer and lot number of the device involved in this complaint was not provided.Therefore, it is unknown if the device involved was abbvie branded tubing.Conservatively, abbvie has chosen to report this complaint due to the potential that the device involved could have been abbvie branded tubing.The device involved in the event remained implanted in the patient and was not returned; therefore, a return sample evaluation is unable to be performed.Gastrointestinal ulcers are a known complication of a peg tube placement.If any further relevant information is identified or obtained, a supplemental medwatch will be filed.
|
On an unknown date, a patient underwent a procedure for the placement of percutaneous endoscopic gastrostomy (peg) tube with jejunal (peg-j) tube.On (b)(6) 2021, the patient experienced muscle tone loss, tremors, freezing, and weakness.On an unknown date, the patient experienced vomiting blood.The neurologist suspected the j-tube was not in the correct position.On (b)(6) 2021, the patient underwent an endoscopy to re-position the j-tube.During the endoscopy, am inactive gi bleed from esophageal and stomach ulcers was discovered.The j-tube was re-positioned during the endoscopy.The hemoglobin of the patient was 7.5.On (b)(6) 2021, the patient was hospitalized and received a unit of blood.The patient was also treated with pepcid and iron.On (b)(6) 2021, the patient had subsequent hemoglobin levels of 8.2 and 8.3.The patient was discharged from the hospital on (b)(6) 2021.
|